InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Kaufmann Gunnar F., Directeur Scientifique. Officer active across 1 company, notably Oncternal Therapeutics, Inc.. Cumulatively, 2 reports have been recorded. Activity tracked since 3 January 2022. The latest transaction was filed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
29,867 shares0Common StockSEC:0001209191-22-001972
29,867 shares0Common StockSEC:0001209191-22-001972:0
2 of 2 declarations
About Kaufmann Gunnar F.
Gunnar F. Kaufmann is the Chief Scientific Officer at Oncternal Therapeutics, Inc. In this role, he oversees the company's research and development activities. His scientific expertise is essential to guide research initiatives and ensure innovation.
